Savara GAAP EPS of -0.12 misses by 0.01

SVRA Stock  USD 3.36  0.20  5.62%   
About 62% of Savara's investor base is looking to short. The analysis of the overall investor sentiment regarding Savara Inc suggests that many traders are alarmed. The current market sentiment, together with Savara's historical and current headlines, can help investors time the market. In addition, many technical investors use Savara Inc stock news signals to limit their universe of possible portfolio assets.
  
Savara reports Q2 2024 financial results, with GAAP EPS missing by 0.01.

Read at seekingalpha.com
seekingalpha News
  

Savara Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Savara can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Savara Fundamental Analysis

We analyze Savara's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Savara using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Savara based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Sales

Price To Sales Comparative Analysis

Savara is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Savara Inc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Savara stock to make a market-neutral strategy. Peer analysis of Savara could also be used in its relative valuation, which is a method of valuing Savara by comparing valuation metrics with similar companies.

Peers

Savara Related Equities

PTIXProtagenic Therapeutics   5.77   
0%
70.0%
KZRKezar Life   2.21   
0%
27.0%
IKNAIkena Oncology   1.80   
0%
22.0%
FENCFennec Pharmaceuticals   1.32   
0%
16.0%
CRNXCrinetics Pharmaceuticals   0.97   
0%
11.0%
ANABAnaptysBio   0.92   
0%
11.0%
RVMDRevolution Medicines   0.53   
0%
6.0%
GPCRStructure Therapeutics   0.06   
1.0%
0%
XOMAOXOMA   0.39   
4.0%
0%
ACLXArcellx   0.82   
10.0%
0%
XLOXilio Development   0.93   
11.0%
0%
DYNDyne Therapeutics   1.19   
14.0%
0%
RZLTRezolute   1.39   
17.0%
0%
SRRKScholar Rock   2.11   
25.0%
0%
TPSTTempest Therapeutics   2.20   
27.0%
0%
AVTEAerovate Therapeutics   2.23   
27.0%
0%
EWTXEdgewise Therapeutics   2.58   
31.0%
0%
XOMAXOMA Corp   2.71   
33.0%
0%
STOKStoke Therapeutics   3.63   
44.0%
0%
TRDAEntrada Therapeutics   4.69   
57.0%
0%
TARAProtara Therapeutics   6.30   
77.0%
0%
ALXOAlx Oncology   8.14   
100.0%
0%

Complementary Tools for Savara Stock analysis

When running Savara's price analysis, check to measure Savara's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Savara is operating at the current time. Most of Savara's value examination focuses on studying past and present price action to predict the probability of Savara's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Savara's price. Additionally, you may evaluate how the addition of Savara to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Transaction History
View history of all your transactions and understand their impact on performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance